THE PROBLEM

Feng lab has three research programs. The first is to understand crosstalk signaling of receptors in the form of receptor dimerization in pathophysiology such as vascular inflammation, metabolism (type 2 diabetes), pain (silent myocardial ischemia), depression, immunosuppression, cancer progression, and etc. The second is about translational research on neurodegenerative diseases and cancer with a focus on novel splicing variants of critical genes that are known to play an important role in depression, neurodegeneration, neuroregeneration, exosome biology, tumorigenesis, and cancer progression. The last is to develop novel technologies for genome editing and epigenome editing. These research programs, from understanding of molecular mechanisms of physiology and pathogenesis of diseases to developing of problem-solving technologies, aim to develop novel therapeutics and diagnostics.

 

"These research programs, from understanding of molecular mechanisms of physiology and pathogenesis of diseases to developing of problem-solving technologies, aim to develop novel therapeutics and diagnostics."

YING-HONG FENG, M.D., Ph.D
DEPARTMENT OF PHARMACOLOGY & MOLECULAR THERAPEUTICS